Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells

The hypersialylated erythropoiesis stimulating agent (ESA) darbepoetin alfa was developed for the treatment of anemia, and has also been reported to have other nonerythropoietic effects. This study outlines one such effect against the toxicity of the radiocontrast medium (RCM) sodium diatrizoate (Na...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreucci, Michele, Provenzano, Michele, Faga, Teresa, Gagliardi, Ida, Pisani, Antonio, Perticone, Maria, Coppolino, Giuseppe, De Sarro, Giovambattista, Serra, Raffaele, Michael, Ashour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044868/
https://www.ncbi.nlm.nih.gov/pubmed/33868961
http://dx.doi.org/10.1016/j.toxrep.2021.03.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044868/
https://www.ncbi.nlm.nih.gov/pubmed/33868961
http://dx.doi.org/10.1016/j.toxrep.2021.03.028

Ejemplares similares